InvestorsHub Logo
Followers 664
Posts 46976
Boards Moderated 1
Alias Born 03/30/2009

Re: None

Monday, 04/23/2018 7:49:57 PM

Monday, April 23, 2018 7:49:57 PM

Post# of 48316
$ONCS Something to consider as OncoSec is in trials with Merck's Keytruda:

Merck's Keytruda Could Soon Be Worth $16 Billion As It Flies Past Bristol's Opdivo

Merck (MRK) popped to a three-month high Monday after Goldman Sachs suggested its cancer drug, Keytruda, could be a $16 billion asset by 2025.


Complete article can be found here:

https://www.investors.com/news/technology/merck-bristol-lung-cancer-battle/?refcode=NwsLtrTech-20180423-PM-4%3AApril%3A2018%3A2Q%3ANewsLetter%3AEmail%3ANwsLtrTech20180423PM%3ATechnology%3A3291637%3Ana%3Ana

Success is never final; failure is never fatal. It's courage that counts.--John Wooden (1910-2010)

Courage is being scared to death, but saddling up anyway.--John Wayne (1907-1979)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News